Current News

/

ArcaMax

China committee eyes supply chain, biotech as Moolenaar takes helm

Gopal Ratnam, CQ-Roll Call on

Published in News & Features

WASHINGTON — The House select committee on U.S.-China competition, freshly under new leadership, is training its sights on a range of tech, defense, economic and foreign policy issues on the heels of a major victory on the bill to force the divestiture of TikTok.

Mike Gallagher, R-Wis., last week left Congress and stepped down as chairman of the House Select Committee on the Strategic Competition between the United States and the Chinese Communist Party. His replacement as chair, Michigan Republican Rep. John Moolenaar, said in a statement on Monday that he will focus on preventing “the CCP from stealing our technology, co-opting businesses, and harassing people on American soil.”

“We will examine the most critical areas of our supply chain so we can reduce our dependence on the CCP,” Moolenaar said.

Legislative measures that the committee is championing now need to be shepherded through relevant congressional committees, Illinois Rep. Raja Krishnamoorthi, the top Democrat on the panel, said in an interview.

“There are a lot of ongoing issues that pop up that require the kind of focus that this committee has helped to bring,” Krishnamoorthi said, emphasizing the need for the committee to continue its work. “We work very closely with our sister committees and the committees of jurisdiction, but I think we’re able to elevate the importance of some of these issues and raise their profile enough to get attention and action.”

The stand-alone bill forcing TikTok owner ByteDance to divest the app or face a ban in the United States went from introduction by Gallagher, Krishnamoorthi and others to a committee markup and House passage in about a week. That original bill passed the House with overwhelming support, was modified by Speaker Mike Johnson as part of a national security supplemental and was signed by President Joe Biden last week.

 

Krishnamoorthi said another measure championed by the committee that targets the practices of specific companies should be a “no-brainer bill.” The measure would ban federal research funds going to U.S. companies that in turn hire Chinese biotech companies, including MGI, Complete Genomics, WuXi AppTec, and BGI Group and its subsidiaries.

While BGI and MGI are closely linked with the Chinese Communist Party, WuXi has transferred “intellectual property without consent” to Beijing, Krishnamoorthi said.

The committee also is pushing for legislation that would prohibit U.S. investment firms from funneling money into Chinese tech and defense companies and is closely examining China’s propaganda efforts in foreign elections, including Taiwan’s, Krishnamoorthi said.

“We had a hearing on what’s called discourse warfare, which is another term that the Chinese use for propaganda,” Krishnamoorthi said. “That came after the Taiwan elections, and what we’ve heard in Taiwan is that they are deeply concerned about it … and we have to keep a close eye on this” in light of the upcoming U.S. election, he said.

...continued

swipe to next page

©2024 CQ-Roll Call, Inc., All Rights Reserved. Visit cqrollcall.com. Distributed by Tribune Content Agency, LLC.

Comments

blog comments powered by Disqus